- By admin
- By October 30, 2026
2026 AIF | Annual Information Form
Page 1 / 42
Zoom 100%
2026 AIF | Annual Information Form
Earlier from Helix BioPharma
- Helix BioPharma Corp. Announces Fiscal 2026 Year-End Results
- Helix BioPharma Strengthens Biotech Leadership and Corporate Governance through planned Board Changes
- Helix BioPharma Corp. Appoints Markus Loeffler, MD, MBA, as Chief Medical Officer to Support Next Phase of Clinical Development
- Helix Biopharma Corp. Announces Board Composition Changes
- Helix BioPharma Corp. Strengthens Executive Leadership to Support U.S. Listing Strategy and Next Phase of Clinical Development
Follow Helix BioPharma into a list and get an email when it puts out news.
Follow Helix BioPharma